Thomas Shrader
Stock Analyst at BTIG
(1.99)
# 3,111
Out of 5,050 analysts
61
Total ratings
37.74%
Success rate
-4.71%
Average return
Main Sectors:
Stocks Rated by Thomas Shrader
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BHVN Biohaven | Maintains: Buy | $33 → $16 | $8.26 | +93.70% | 4 | Nov 6, 2025 | |
| STOK Stoke Therapeutics | Reiterates: Buy | $39 | $22.86 | +70.60% | 2 | Nov 5, 2025 | |
| ACIU AC Immune | Reiterates: Buy | $8 | $3.30 | +142.42% | 3 | Nov 4, 2025 | |
| ARCT Arcturus Therapeutics Holdings | Maintains: Buy | $48 → $23 | $8.72 | +163.76% | 2 | Oct 22, 2025 | |
| ALEC Alector | Downgrades: Neutral | n/a | $1.28 | - | 4 | Oct 22, 2025 | |
| GANX Gain Therapeutics | Reiterates: Buy | $9 | $1.96 | +359.18% | 4 | Oct 15, 2025 | |
| CMPS COMPASS Pathways | Maintains: Buy | $7 → $14 | $5.45 | +156.88% | 1 | Oct 13, 2025 | |
| COYA Coya Therapeutics | Reiterates: Buy | $15 | $5.76 | +160.42% | 2 | Sep 30, 2025 | |
| HROW Harrow | Reiterates: Buy | $63 | $33.93 | +85.68% | 3 | Sep 29, 2025 | |
| DRUG Bright Minds Biosciences | Initiates: Buy | $72 | $58.79 | +22.47% | 1 | Sep 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.63 | - | 3 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $9 | $4.69 | +91.90% | 1 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $4 | $1.32 | +203.03% | 3 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $160 | $41.65 | +284.15% | 4 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.85 | - | 3 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8 | $0.38 | +2,010.82% | 1 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $180 → $60 | $6.14 | +877.20% | 1 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $7 | $2.88 | +143.06% | 2 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $68 → $13 | $0.69 | +1,793.39% | 3 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $22 | $1.88 | +1,070.21% | 2 | Oct 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $51 | $1.60 | +3,087.50% | 1 | Apr 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $4.73 | +238.27% | 1 | Mar 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.23 | - | 1 | Feb 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $15.02 | - | 2 | Oct 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $3 | $1.07 | +180.37% | 3 | Apr 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $397 → $346 | $155.51 | +122.49% | 3 | Feb 21, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $92.31 | - | 1 | Oct 27, 2017 |
Biohaven
Nov 6, 2025
Maintains: Buy
Price Target: $33 → $16
Current: $8.26
Upside: +93.70%
Stoke Therapeutics
Nov 5, 2025
Reiterates: Buy
Price Target: $39
Current: $22.86
Upside: +70.60%
AC Immune
Nov 4, 2025
Reiterates: Buy
Price Target: $8
Current: $3.30
Upside: +142.42%
Arcturus Therapeutics Holdings
Oct 22, 2025
Maintains: Buy
Price Target: $48 → $23
Current: $8.72
Upside: +163.76%
Alector
Oct 22, 2025
Downgrades: Neutral
Price Target: n/a
Current: $1.28
Upside: -
Gain Therapeutics
Oct 15, 2025
Reiterates: Buy
Price Target: $9
Current: $1.96
Upside: +359.18%
COMPASS Pathways
Oct 13, 2025
Maintains: Buy
Price Target: $7 → $14
Current: $5.45
Upside: +156.88%
Coya Therapeutics
Sep 30, 2025
Reiterates: Buy
Price Target: $15
Current: $5.76
Upside: +160.42%
Harrow
Sep 29, 2025
Reiterates: Buy
Price Target: $63
Current: $33.93
Upside: +85.68%
Bright Minds Biosciences
Sep 8, 2025
Initiates: Buy
Price Target: $72
Current: $58.79
Upside: +22.47%
Jul 1, 2025
Downgrades: Neutral
Price Target: n/a
Current: $1.63
Upside: -
Apr 7, 2025
Maintains: Buy
Price Target: $11 → $9
Current: $4.69
Upside: +91.90%
Mar 24, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $1.32
Upside: +203.03%
Feb 24, 2025
Reiterates: Buy
Price Target: $160
Current: $41.65
Upside: +284.15%
Sep 4, 2024
Downgrades: Neutral
Price Target: n/a
Current: $3.85
Upside: -
Oct 3, 2023
Initiates: Buy
Price Target: $8
Current: $0.38
Upside: +2,010.82%
Jul 28, 2023
Maintains: Buy
Price Target: $180 → $60
Current: $6.14
Upside: +877.20%
May 25, 2023
Maintains: Buy
Price Target: $15 → $7
Current: $2.88
Upside: +143.06%
Mar 28, 2023
Maintains: Buy
Price Target: $68 → $13
Current: $0.69
Upside: +1,793.39%
Oct 5, 2022
Maintains: Buy
Price Target: $15 → $22
Current: $1.88
Upside: +1,070.21%
Apr 20, 2021
Initiates: Buy
Price Target: $51
Current: $1.60
Upside: +3,087.50%
Mar 8, 2021
Initiates: Buy
Price Target: $16
Current: $4.73
Upside: +238.27%
Feb 3, 2021
Downgrades: Neutral
Price Target: n/a
Current: $4.23
Upside: -
Oct 16, 2020
Downgrades: Neutral
Price Target: n/a
Current: $15.02
Upside: -
Apr 3, 2020
Maintains: Buy
Price Target: $4 → $3
Current: $1.07
Upside: +180.37%
Feb 21, 2019
Downgrades: Hold
Price Target: $397 → $346
Current: $155.51
Upside: +122.49%
Oct 27, 2017
Upgrades: Buy
Price Target: n/a
Current: $92.31
Upside: -